When blood sugar starts to rise after a person eats, GLP-1 agonists cause the body to make more insulin. This extra insulin ...

Rapid-acting inhaled insulin (Afrezza) is under FDA review for children ages 4 to 17 with diabetes, said maker MannKind. If ...

GLP-1 weight-loss drugs like Ozempic and Zepbound might help protect people from health risks related to sleep apnea, ...

Weight-loss drugs like Ozempic and Zepbound might help protect people from health risks related to sleep apnea, a new study ...

Eli Lilly has guided its oral GLP-1 drug candidate orforglipron through two more late-phase tests in Type 2 diabetes, racking ...

(CNN) — The use of drugs like Ozempic, Wegovy and Zepbound in people with type 1 diabetes has risen sharply over the past decade, a new study finds, even though there’s little information on the drugs ...

In the end, people taking GLP-1 drugs consistently reported feeling less intoxicated, the study found. Data taken during the ...

With the explosion in popularity of GLP-1 drugs like Ozempic, another industry has popped up, claiming to offer “natural” ...

Explore how functional ingredients are challenging GLP-1 drugs in weight management – and what this shift means for food and ...

The risks for postmenopausal breast cancer or thyroid cancer were not reduced in association with GLP-1 RA use. HealthDay News — For patients with type 2 diabetes (T2D), glucagon-like peptide 1 ...

In recent years, GLP-1 agonist medications like Ozempic have gained notoriety for their weight loss effects and blood sugar regulation. However, these pharmaceuticals come with a host of potential ...